Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola

Muhammad-Abbas Conteh, Susan T Goldstein, Haja R Wurie, Jane Gidudu, Durodami Radcliffe Lisk, Rosalind J Carter, Jane F Seward, Lee M Hampton, David Wang, Lauren E Andersen, Melissa Arvay, Stephanie J Schrag, Peter Dawson, Augustin E Fombah, Carey R Petrie, Daniel R Feikin, James B W Russell, Robert Lindblad, S A S Kargbo, Mohamed Samai, Barbara E Mahon, Muhammad-Abbas Conteh, Susan T Goldstein, Haja R Wurie, Jane Gidudu, Durodami Radcliffe Lisk, Rosalind J Carter, Jane F Seward, Lee M Hampton, David Wang, Lauren E Andersen, Melissa Arvay, Stephanie J Schrag, Peter Dawson, Augustin E Fombah, Carey R Petrie, Daniel R Feikin, James B W Russell, Robert Lindblad, S A S Kargbo, Mohamed Samai, Barbara E Mahon

Abstract

ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Figures

Figure 1.
Figure 1.
Ebola case definitions used during the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). aSymptoms in bold are those not known to be related to the study vaccine.
Figure 2.
Figure 2.
Algorithm for initial management of illness in participants from the Sierra Leone Trial to Introduce a Vaccine Against Ebola. Abbreviations: EVD, Ebola virus disease; PPE, personal protective equipment.
Figure 3.
Figure 3.
Flow diagram of participants from the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) who were evaluated for Ebola.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться